The antiparkinsonian actions of L-DOPA are attenuated by antagonism of α1-adrenoceptors in MPTP-lesioned macaques

被引：0
|
作者：
Visanji, N. P.
Fox, S. H.
Johnston, T. H.
Millan, M. J.
Brotchie, J. M.
机构：
来源：
MOVEMENT DISORDERS | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1122
引用
收藏
页码：S639 / S639
页数：1
相关论文
共 50 条
  • [1] 5-HT2A receptor levels increase in MPTP-lesioned macaques treated chronically with L-DOPA
    Huot, Philippe
    Johnston, Tom H.
    Winkelmolen, Lieke
    Fox, Susan H.
    Brotchie, Jonathan M.
    NEUROBIOLOGY OF AGING, 2012, 33 (01) : 194.e5 - 194.e15
  • [2] L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease
    Huot, Philippe
    Johnston, Tom H.
    Koprich, James B.
    Fox, Susan H.
    Brotchie, Jonathan M.
    NEUROPHARMACOLOGY, 2012, 63 (05) : 829 - 836
  • [3] The α2 adrenergic antagonist fipamezole prolongs the anti-parkinsonian actions of L-DOPA in the MPTP-lesioned macaque
    Johnston, T. H.
    Savola, J.-M.
    Fox, S. H.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2007, 22 : S6 - S7
  • [4] The α2 adrenergic antagonist, fipamezole, prolongs the anti-parkinsonian actions of L-DOPA in the MPTP-lesioned macaque
    Johnston, T. H.
    Fox, S. H.
    Savola, J.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2006, 21 : S640 - S640
  • [5] Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)
    Maratos, EC
    Jackson, MJ
    Pearce, RKB
    Jenner, P
    MOVEMENT DISORDERS, 2001, 16 (04) : 631 - 641
  • [6] PYM50028 (Cogane™), an Orally Active Neurotrophic Factor Modulator Enhances the Effect of L-DOPA in MPTP-Lesioned Macaques
    Johnston, T. H.
    Koprich, J. B.
    Fox, S. H.
    Ward, C. L.
    Hickling, R. I.
    Howson, P. A.
    Brotchie, J. M.
    MOVEMENT DISORDERS, 2010, 25 : S637 - S637
  • [7] Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease
    Nash, JE
    Fox, SH
    Henry, B
    Hill, MP
    Peggs, D
    McGuire, S
    Maneuf, Y
    Hille, C
    Brotchie, JM
    Crossman, AR
    EXPERIMENTAL NEUROLOGY, 2000, 165 (01) : 136 - 142
  • [8] Levetiracetam interferes with the L-dopa priming process in MPTP-lesioned drug-naive marmosets
    Hill, MP
    Brotchie, JM
    Crossman, AR
    Bezard, E
    Michel, A
    Grimée, GE
    Klitgaard, H
    CLINICAL NEUROPHARMACOLOGY, 2004, 27 (04) : 171 - 177
  • [9] Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset
    Cynthia Kwan
    Stephen G. Nuara
    Jim C. Gourdon
    Philippe Huot
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 1685 - 1692
  • [10] Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset
    Kwan, Cynthia
    Nuara, Stephen G.
    Gourdon, Jim C.
    Huot, Philippe
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (08) : 1685 - 1692
12345